Heart disease remains the number 1 cause of death among individuals worldwide. To reduce this threat, a variety of screenings are used to monitor heart health, including blood tests to check levels of ...

Lp(a)] is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD), with levels >50 mg/dL affecting 20–30% of the global population. Despite therapeutic ...

Lipoprotein(a) as well as two oxidized phospholipids (OxPLs) are all associated with multivessel coronary artery disease detected on angiography and also linked to a higher risk of major adverse ...

Lp(a)] is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD), with levels >50 mg/dL affecting 20–30% of the global population.

Icosapent ethyl (Vascepa; Amarin) remains effective at reducing cardiovascular events in patients with elevated triglycerides but relatively well-controlled LDL cholesterol on a statin irrespective of ...

Experts share their final thoughts on the discussion, offering key takeaways and reflections on the importance of lipoprotein(a) (Lp[a]) testing and its role in improving cardiovascular risk ...

Lipoprotein a — Lp(a) — is a new focus of interest as an independent cardiovascular (CV) risk factor, with several new drugs that lower this lipoprotein now on the horizon. Given that Lp(a) levels are ...

Please provide your email address to receive an email when new articles are posted on . Lp(a) fluctuates throughout a woman’s lifetime. High levels are linked to adverse pregnancy outcomes. Data are ...